Literature DB >> 20936241

Integrated biomimetic carbon nanotube composites for in vivo systems.

Manoj Kumar Singh1, Jose Gracio, Philip LeDuc, Paula P Gonçalves, Paula A A P Marques, Gil Gonçalves, Filipa Marques, Virgília S Silva, Fernando Capela e Silva, Joana Reis, José Potes, António Sousa.   

Abstract

As interest in using carbon nanotubes for developing biologically compatible systems continues to grow, biological inspiration is stimulating new directions for in vivo approaches. The ability to integrate nanotechnology-based systems in the body will provide greater successes if the implanted material is made to mimic elements of the biological milieu especially through tuning physical and chemical characteristics. Here, we demonstrate the highly successful capacity for in vivo implantation of a new carbon nanotube-based composite that is, itself, integrated with a hydroxyapatite-polymethyl methacrylate to create a nanocomposite. The success of this approach is grounded in finely tailoring the physical and chemical properties of this composite for the critical demands of biological integration. This is accomplished through controlling the surface modification scheme, which affects the interactions between carbon nanotubes and the hydroxyapatite-polymethyl methacrylate. Furthermore, we carefully examine cellular response with respect to adhesion and proliferation to examine in vitro compatibility capacity. Our results indicate that this new composite accelerates cell maturation through providing a mechanically competent bone matrix; this likely facilitates osteointegration in vivo. We believe that these results will have applications in a diversity of areas including carbon nanotube, regeneration, chemistry, and engineering research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936241     DOI: 10.1039/c0nr00237b

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  8 in total

1.  TiO2-Based Nanotopographical Cues Attenuate the Restenotic Phenotype in Primary Human Vascular Endothelial and Smooth Muscle Cells.

Authors:  Yiqi Cao; Tejal A Desai
Journal:  ACS Biomater Sci Eng       Date:  2020-01-17

2.  In vitro and in vivo radiosensitization induced by hydroxyapatite nanoparticles.

Authors:  Sheng-Hua Chu; Surya Karri; Yan-Bin Ma; Dong-Fu Feng; Zhi-Qiang Li
Journal:  Neuro Oncol       Date:  2013-03-21       Impact factor: 12.300

3.  Evaluation of the in vitro biocompatibility of PMMA/high-load HA/carbon nanostructures bone cement formulations.

Authors:  Gil Gonçalves; María-Teresa Portolés; Cecilia Ramírez-Santillán; María Vallet-Regí; Ana Paula Serro; José Grácio; Paula A A P Marques
Journal:  J Mater Sci Mater Med       Date:  2013-08-21       Impact factor: 3.896

4.  Inhibition of human glioma U251 cells growth in vitro and in vivo by hydroxyapatite nanoparticle-assisted delivery of short hairpin RNAs against SATB1.

Authors:  Sheng-Hua Chu; Zhang-Ming Zhou; Dong-Fu Feng; Yan-Bin Ma
Journal:  Mol Biol Rep       Date:  2013-12-27       Impact factor: 2.316

Review 5.  Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies.

Authors:  Daniela Y Santiesteban; Kelsey Kubelick; Kabir S Dhada; Diego Dumani; Laura Suggs; Stanislav Emelianov
Journal:  Ann Biomed Eng       Date:  2015-12-21       Impact factor: 4.219

6.  Biomimetic three-dimensional nanocrystalline hydroxyapatite and magnetically synthesized single-walled carbon nanotube chitosan nanocomposite for bone regeneration.

Authors:  Owen Im; Jian Li; Mian Wang; Lijie Grace Zhang; Michael Keidar
Journal:  Int J Nanomedicine       Date:  2012-04-24

Review 7.  Carbon nanotube interaction with extracellular matrix proteins producing scaffolds for tissue engineering.

Authors:  Fernanda M P Tonelli; Anderson K Santos; Katia N Gomes; Eudes Lorençon; Silvia Guatimosim; Luiz O Ladeira; Rodrigo R Resende
Journal:  Int J Nanomedicine       Date:  2012-08-14

8.  Hydroxyapatite nanoparticles inhibit the growth of human glioma cells in vitro and in vivo.

Authors:  Sheng-Hua Chu; Dong-Fu Feng; Yan-Bin Ma; Zhi-Qiang Li
Journal:  Int J Nanomedicine       Date:  2012-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.